Jubilant Life Sciences has received the final USFDA approval for Darifenacin Extended-Release Tablets, used for the treatment of urinary incontinence. The company has received Abbreviated New Drug Application (ANDA) final approval for strengths 7.5 mg and 15 mg which are generic version of Enablex of Allergan Plc.
Company Profile : Jubilant Life Sciences Ltd
Leave a Reply